Article
type: Class

Document
type: Class

Anualidad
type: Class

Academic Article
type: Class

Information Content Entity
type: Class

Continuant
type: Class

2022
type: Class

Entity
type: Class

Generically Dependent Continuant
type: Class

RDF description of Antifibrotic drugs as therapeutic tools in resistant melanoma - http://research.umh.es/vivo/pub/articulo/240859
type: Document
rights: termsOfUse
date: 2026-08-16T20:49:13
publisher: Antifibrotic drugs as therapeutic tools in resistant melanoma

Antifibrotic drugs as therapeutic tools in resistant melanoma
type: 2022
related by: Autor:126397-Artículo:240859
type: Academic Article
date time value: 240859 pubdate
included: Instituto de Neurociencias 2022
has publication venue: EMBO MOLECULAR MEDICINE
type: Article
page start: 1
type: Document
type: Entity
most specific type: Academic Article
page end: 2
type: Thing
ARG_2000028: 240859 vcard
related by: Autor:196653-Artículo:240859
type: Generically Dependent Continuant
type: Information Content Entity
type: Continuant
most specific type: 2022
type: Anualidad

Autor:126397-Artículo:240859
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Antifibrotic drugs as therapeutic tools in resistant melanoma

Instituto de Neurociencias 2022
type: InstituteReport
type: 2022
type: Anualidad
type: Thing
type: ResearchReport
includes: Antifibrotic drugs as therapeutic tools in resistant melanoma

EMBO MOLECULAR MEDICINE
type: Entity
type: Generically Dependent Continuant
type: Periodical
type: Continuant
publication venue for: Antifibrotic drugs as therapeutic tools in resistant melanoma
type: Information Content Entity
type: Collection
type: Thing
type: Journal

Autor:196653-Artículo:240859
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Antifibrotic drugs as therapeutic tools in resistant melanoma